AstraZeneca and Ironwood announce linaclotide collaboration for China

AstraZeneca and Ironwood announce linaclotide collaboration for China

[at noodls] – AstraZeneca and Ironwood Pharmaceuticals, Inc. announced today an agreement to co-develop and co-commercialise Ironwood’s linaclotide in China. Linaclotide is the first and only guanylate cyclase-C (GC-C) … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

Share this post